Reach Us +44-1202-068036
Editor - Xiaoyan Zhang | Mount Sinai School of Medicine | 11252
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Xiaoyan Zhang

Xiaoyan Zhang
Xiaoyan Zhang
Department of Pharmacology and Systems Therapeutics
Mount Sinai School of Medicine
Mount Sinai School of Medicine


Dr. Xiaoyan Zhang obtained her Ph.D. degree from University of Louisville majoring in Pharmacology and Toxicology. She also held master degree from Fudan University and M.D. degree from Zhengzhou University in China. Currently she is working in Mount Sinai School of Medicine as a senior post-doc scientist in the Department of Pharmacology and Systems Therapeutics.She has published highly-cited articles in the prestigious peer-viewed journals.She has also been serving as reviewer for peer-viewed journals and been an active member in the American Society for Clinical Pharmacology and Therapeutics (ASCPT) and American Association for Cancer Research (AACR).

Research Interest

Her research focused on drug metabolizing enzyme polymorphism, PK/PD modeling and simulation, characterization of both monoclonal antibody and small tyrosine kinase inhibitor in various cancer and autoimmune disease models.



Global Speakers in the subject

Global Experts in the subject


Nuclear Receptor FXR: A Potential Therapeutic Target for the Treatment of Diseases with Impaired Urine Concentration

Genetic Variation in Prediction of Drug Efficacy and Toxicity

Xiaoyan Zhang and Youfei Guan
Short Communication: J Mol Biomark Diagn 2016, 7: 278
DOI: 10.4172/2155-9929.1000278
Xiaoyan Zhang
Editorial: Clin Pharmacol Biopharm 2013, 2:e113
DOI: 10.4172/2167-065X.1000e113
Leave Your Message 24x7